Immunocore
IMCR

Immunocore (IMCR) analyst forecast and price target

Recent analyst ratings

FirmActionRatingPrice targetDate
JP MorganMaintainedOverweight$50.00Aug 21, 2026
MizuhoMaintainedNeutral$35.00 from $34.00Aug 3, 2026
HC Wainwright & Co.MaintainedBuy$100.00Apr 20, 2026
HC Wainwright & Co.MaintainedBuy$100.00Apr 14, 2026
JefferiesDowngradedBuy → Hold$33.00 from $48.00Mar 16, 2026
NeedhamMaintainedBuy$75.00 from $71.00Feb 26, 2026
HC Wainwright & Co.MaintainedBuy$100.00Feb 4, 2026
UBSInitiated CoverageSell → Buy$55.00 from $24.00Jan 7, 2026
Morgan StanleyMaintainedEqual-Weight$36.00 from $34.00Nov 10, 2025
Wells FargoInitiated CoverageOverweight$60.00Oct 31, 2025
HC Wainwright & Co.MaintainedBuy$100.00Oct 22, 2025
GuggenheimInitiated CoverageNeutralSep 18, 2025
HC Wainwright & Co.MaintainedBuy$100.00Jun 2, 2025
OppenheimerMaintainedOutperform$86.00 from $85.00May 8, 2025
JP MorganMaintainedOverweight$50.00 from $54.00Apr 14, 2025
NeedhamMaintainedBuy$71.00Apr 10, 2025
MizuhoMaintainedNeutral$33.00 from $38.00Apr 7, 2025
NeedhamMaintainedBuy$71.00Mar 12, 2025
HC Wainwright & Co.MaintainedBuy$100.00Mar 12, 2025
Morgan StanleyInitiated CoverageEqual-Weight$35.00Mar 7, 2025

Frequently asked questions

  • What is the latest analyst rating on IMCR?

    On Aug 21, 2026, JP Morgan maintained Immunocore at Overweight with a price target of $50.00.

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.